Death from hemophagocytic lymphohistiocytosis syndrome due to generalized hemorrhage

Hemophagocytic lymphohistiocytosis (HLH) is the result of excessive cytokine release, leading to over-response by immune cells, such as macrophages and T lymphocytes. Here, we report a lethal case of HLH with a complete clinical course. The patient was a 45-year-old man with fever and chills since two months ago plus splenomegaly, hepatomegaly, and pancytopenia. The Anti-HBc IgM was positive, but the HBS antigen, anti-HCV, and HBS antibody were negative. Assessment for cirrhosis was carried out by FibroScan, which showed F4 grade. The biopsy sampling was impossible due to the low platelet count. During admission, generalized bleeding was developed and led to alveolar hemorrhage, which subsequently resulted in the patient's death. Liver necropsy certified the diagnosis of hemophagocytic syndrome. Overall, according to the reported case in this paper, it should be remembered that secondary HLH is an inflammatory phenomenon due to different conditions, such as latent newly-developed infections. © 2019

In vitro evaluation of sustained released matrix tablets containing ibuprofen: a model poorly water-soluble drug

ABSTRACT A matrix system was developed that releases ibuprofen (IB) over a 12-hour period and the influence of the polymer type and concentration on the release rate of the drug was evaluated. Tablets containing different concentrations of Carbopol (CP), hydroxypropyl methylcellulose (HPMC), or ethyl cellulose (EC) were prepared using direct compression and the drug content, content uniformity, hardness, friability, dissolution performance, and in vitro release kinetics were examined. Formulated tablets were found to be within acceptable limits for physical and chemical parameters. The release kinetics of the Carbopol(r)971P 8% formulation showed the best linearity (r 2 =0.977) in fitting zero-order kinetics, suggesting the release rate was time independent. The drug release from tablets containing 8% CP was extended over approximately 18 hours and the release kinetics were nearly linear, suggesting that this system has the potential to maintain constant plasma drug concentrations over 12 hours, which could reduce the frequency of administration and the occurrence of adverse effects associated with repeated administration of conventional IB tablets

Effect of Nanopowder Addition on the Sintering of Water-Atomized Iron Powder

A promising method of improving the densification of powder metallurgical steel components is to blend nanopowder with the otherwise typically used micrometre-sized powder. The higher surface-to-volume ratio of nanopowder is hypothesized to accelerate the sintering process and increase the inter-particle contact area between the powder particles. This is supposed to enhance the material transport and improve the densification. In the present investigation, water-atomized iron powder (−\ua045 μm) was mixed separately with pure iron and low-carbon steel nanopowder, each at a ratio of 95 to 5 pct. These powder mixes were compacted at different pressures (400, 600 and 800 MPa) and then sintered at 1350 \ub0C in a pure hydrogen atmosphere. The sintering behavior of the powder blend compacts was compared to that of the compact with micrometre-sized powder only. Densification commenced at much lower temperatures in the presence of nanopowder. To understand this, sintering at intermittent temperatures such as 500 \ub0C and 700 \ub0C was conducted. The fracture surface revealed that the nanopowder was sintered at between 500 \ub0C and 700 \ub0C, which in turn contributed to the densification of the powder mix at the lower temperature range. Based on the sintering experiments, an attempt was made to calculate the activation energy and identify the associated sinter mechanism using two different approaches. It was shown that the first approach yielded values in agreement with the grain-boundary diffusion mechanism. As the nanopowder content increased, there was an increase in linear shrinkage during sintering